A detailed history of Planned Solutions, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Planned Solutions, Inc. holds 2,429 shares of NVO stock, worth $257,789. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,429
Previous 2,154 12.77%
Holding current value
$257,789
Previous $307,000 5.86%
% of portfolio
0.12%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$119.07 - $145.42 $32,744 - $39,990
275 Added 12.77%
2,429 $289,000
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $28,182 - $37,513
276 Added 14.7%
2,154 $276,000
Q4 2023

Jan 17, 2024

BUY
$87.78 - $105.45 $164,850 - $198,035
1,878 New
1,878 $194,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Planned Solutions, Inc. Portfolio

Follow Planned Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planned Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Planned Solutions, Inc. with notifications on news.